News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
201 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42568)
2024 (38485)
2025 (25165)
Month
January (3339)
February (3294)
March (4068)
April (3458)
May (4782)
June (3455)
July (2690)
August (3589)
September (3334)
October (3977)
November (4082)
December (2500)
Day
1 (228)
2 (201)
3 (256)
4 (88)
6 (3)
7 (176)
8 (256)
9 (209)
10 (241)
11 (82)
12 (1)
13 (1)
14 (211)
15 (144)
16 (102)
17 (110)
18 (49)
20 (2)
21 (105)
22 (152)
23 (135)
24 (137)
25 (50)
26 (2)
27 (5)
28 (142)
29 (180)
30 (175)
31 (146)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
6
7
8
9
10
11
12
13
14
15
16
17
18
20
21
22
23
24
25
26
27
28
29
30
31
Genetown
Stoke Therapeutics to Present at the Canaccord Genuity 43rd Annual Growth Conference
Stoke Therapeutics, Inc. today announced that management will present at the Canaccord Genuity 43rd Annual Growth Conference on Wednesday, August 9, 2023, at 4:30 p.m. ET.
August 2, 2023
·
1 min read
Business
Catena Biosciences Expands Executive Leadership Team, Appoints Saurabh Johri as Chief Business Officer and Rick Kendall as Chief Scientific Officer
Catena Biosciences Expands Executive Leadership Team, Appoints Saurabh Johri as Chief Business Officer and Rick
August 2, 2023
·
5 min read
BioMidwest
Sierra Space and BioServe Space Technologies to Demonstrate In-Space Stem Cell Production to Better Treat Cancer Patients on Earth
Sierra Space announced it has developed a pathfinder spaceflight investigation in collaboration with BioServe Space Technologies and other partners to grow hematopoietic stem cells in microgravity to better help patients on Earth undergoing treatment for blood cancer.
August 2, 2023
·
6 min read
Genetown
Yield10 Bioscience Announces Positive Results in the First Field Test of Stacked Herbicide Tolerance Traits in Camelina, Supporting Large Acreage Production of Low-carbon Intensity Feedstock Oil for the Biofuel Market
Yield10 Bioscience, Inc. today announced positive results in the first field test of stacked herbicide tolerance (“HT”) traits in Camelina.
August 2, 2023
·
6 min read
Deals
Adamis Pharmaceuticals Announces Pricing of $8.0 Million Public Offering
Adamis Pharmaceuticals Corporation today announced the pricing of its public offering of 5,930,000 units at a public offering price of $1.35 per unit.
August 2, 2023
·
5 min read
Business
RVL Pharmaceuticals plc to Discuss Second Quarter 2023 Financial Results and Provide Commercial Update-- Conference call to be held Monday, August 14, 2023, at 8:30 a.m. ET --
RVL Pharmaceuticals plc today announced that the Company will release its second quarter 2023 financial results and provide a commercial update on Monday, August 14, 2023, before U.S. financial markets open.
August 2, 2023
·
2 min read
Business
Cryoport to Report Second Quarter 2023 Financial Results on August 9, 2023
Cryoport, Inc. today announced that the Company will report financial results for the second quarter ended June 30, 2023 on Wednesday, August 9, 2023 after U.S. markets close.
August 2, 2023
·
4 min read
Policy
American Aires Announces Record Monthly Order Volume
American Aires Inc. (CSE: WIFI) (OTC Pink: AAIRF) (“Aires” or the “Company”), a leader in scientifically-proven EMF modulation technology, announces a record in monthly order volume.
August 2, 2023
·
5 min read
FDA
Satellos Bioscience Receives Orphan Drug Designation from the U.S. FDA for SAT-3153, a First-in-Class Small Molecule Therapeutic for Duchenne Muscular Dystrophy
Company also recently received Rare Pediatric Disease Designation from the FDA for SAT-3153 for the treatment of pediatric patients with Duchenne
August 2, 2023
·
7 min read
BWL Investments Announces Hydromer Inc. (OTC:HYDI) Shareholders Demand Shareholders Meeting
BWL Investments (BWL) and its affiliates are large, concerned shareholders of Hydromer, Inc., a New Jersey corporation.
August 2, 2023
·
1 min read
Previous
10 of 21
Next